Morning All:
Shorts are back into the 4%'s after the ASX rebalancing. It may continue to fall in the next few readings due to funds closing further positions and the depressed share price, but I imagine it will stay around here without further updates.
On a longer time frame, it hasn't been back at this level since the share price was hammered due to the capital raise that funded the Azer-Cell acquisition. We will see if like that year, CF33 / Oncarlytics data will be impressive enough to get the share price out of the 3c's and to something more substantial. Cheers, and DYOR.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $298.4K | 23.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1599857 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 2241176 | 12 |
View Market Depth
| Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |